Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ProPhase Labs (PRPH) Capital Leases: 2023-2025

Historic Capital Leases for ProPhase Labs (PRPH) over the last 3 years, with Sep 2025 value amounting to $965,000.

  • ProPhase Labs' Capital Leases fell 75.16% to $965,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $965,000, marking a year-over-year decrease of 75.16%. This contributed to the annual value of $2.6 million for FY2024, which is 36.68% down from last year.
  • As of Q3 2025, ProPhase Labs' Capital Leases stood at $965,000, which was down 48.91% from $1.9 million recorded in Q2 2025.
  • ProPhase Labs' Capital Leases' 5-year high stood at $4.4 million during Q3 2023, with a 5-year trough of $965,000 in Q3 2025.
  • Moreover, its 3-year median value for Capital Leases was $3.2 million (2024), whereas its average is $3.0 million.
  • In the last 5 years, ProPhase Labs' Capital Leases spiked by 300.37% in 2024 and then slumped by 75.16% in 2025.
  • Quarterly analysis of 3 years shows ProPhase Labs' Capital Leases stood at $4.1 million in 2023, then plummeted by 36.68% to $2.6 million in 2024, then crashed by 75.16% to $965,000 in 2025.
  • Its Capital Leases was $965,000 in Q3 2025, compared to $1.9 million in Q2 2025 and $2.7 million in Q1 2025.